- Home
- BPMC vs PAAS Comparison
BPMC vs PAAS Comparison
Compare BPMC & PAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- PAAS
- Stock Information
- Founded
- BPMC 2008
- PAAS 1994
- Country
- BPMC United States
- PAAS Canada
- Employees
- BPMC N/A
- PAAS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- PAAS
- Sector
- BPMC Health Care
- PAAS
- Exchange
- BPMC Nasdaq
- PAAS Nasdaq
- Market Cap
- BPMC 6.7B
- PAAS 7.7B
- IPO Year
- BPMC 2015
- PAAS 1995
- Fundamental
- Price
- BPMC $111.96
- PAAS $21.91
- Analyst Decision
- BPMC Buy
- PAAS Buy
- Analyst Count
- BPMC 19
- PAAS 5
- Target Price
- BPMC $122.72
- PAAS $24.00
- AVG Volume (30 Days)
- BPMC 789.4K
- PAAS 2.4M
- Earning Date
- BPMC 02-13-2025
- PAAS 02-19-2025
- Dividend Yield
- BPMC N/A
- PAAS 1.82%
- EPS Growth
- BPMC N/A
- PAAS N/A
- EPS
- BPMC N/A
- PAAS N/A
- Revenue
- BPMC $434,415,000.00
- PAAS $2,673,400,000.00
- Revenue This Year
- BPMC $108.09
- PAAS $24.56
- Revenue Next Year
- BPMC $39.34
- PAAS $12.58
- P/E Ratio
- BPMC N/A
- PAAS N/A
- Revenue Growth
- BPMC 100.93
- PAAS 32.22
- 52 Week Low
- BPMC $72.24
- PAAS $12.16
- 52 Week High
- BPMC $121.90
- PAAS $26.05
- Technical
- Relative Strength Index (RSI)
- BPMC 71.32
- PAAS 55.03
- Support Level
- BPMC $103.67
- PAAS $20.99
- Resistance Level
- BPMC $107.88
- PAAS $22.00
- Average True Range (ATR)
- BPMC 4.24
- PAAS 0.67
- MACD
- BPMC 2.43
- PAAS 0.15
- Stochastic Oscillator
- BPMC 97.93
- PAAS 86.30
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.